JMDC Inc. (TYO:4483)
Japan · Delayed Price · Currency is JPY 3,785.00
-145.00 (-3.69%)
At close: Dec 10, 2025
JMDC Inc. Revenue
JMDC Inc. had revenue of 12.36B JPY in the quarter ending September 30, 2025, with 14.66% growth. This brings the company's revenue in the last twelve months to 45.61B, up 20.55% year-over-year. In the fiscal year ending March 31, 2025, JMDC Inc. had annual revenue of 41.72B with 28.85% growth.
Revenue (ttm)
45.61B
Revenue Growth
+20.55%
P/S Ratio
5.43
Revenue / Employee
19.99M
Employees
2,187
Market Cap
247.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 41.72B | 9.34B | 28.85% |
| Mar 31, 2024 | 32.38B | 4.57B | 16.44% |
| Mar 31, 2023 | 27.81B | 6.00B | 27.48% |
| Mar 31, 2022 | 21.81B | 5.04B | 30.07% |
| Mar 31, 2021 | 16.77B | 4.61B | 37.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |